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WARNER REPORT ON ADVERSE REACTIONS TO FOODS AND FOOD INGREDIENTS 
EXPRESSED ON 22 SEPTEMBER 1995 
Summary 
1. The Scientific Committee for Food was asked to prepare a report on Adverse Reactions to Foods 
and Food ingredients taking into account the identity of those foods, food components and food 
ingredients which are associated with adverse reactions to food. This report does so and also 
attempts to characterise the adverse reactions frequently observed allowing considerable 
latitude in the meaning of the term 'adverse reactions'. The report also attempts to examine the 
frequency of such adverse reactions and to comment on their geographic distribution and public 
health significance. 
2. The report presents a series of definitions which apply to the many allied and sometimes 
overlapping terms used in this topic. The broadest term 'Food Intolerance' excludes 
psychologically-mediated reactions and includes those of both an immunological and non-
immunological nature. The latter may be related to an enzyme deficiency, to a pharmacological 
reaction or, as in the majority of cases to unknown causes. The term 'Food Allergy' always implies 
an immunological basis to the adverse reaction. The term 'Food Aversion' implies a 
psychological dimension which may overlap with an existing or former immunologically-based 
adverse reaction. 
3. Food allergy, that is an adverse reaction involving the immune system, is often difficult to 
diagnose. The adverse reactions range from relatively rare life-threatening allergic reactions to 
far more commonplace adverse reactions which, while not being life threatening, lead to illness 
and reduced quality of life. While allergic reactions can occur with any food or food ingredient 
some are more common than others. This, however, requires qualification since focal, 
geographically isolated clusters of an allergy to a specific food can occur. 
4. Common food allergens include cow's milk, fruits, legumes (especially peanuts and soybean), eggs, 
crustaceae (shrimps, crab, lobster and cray-fish), tree nuts (almonds, walnuts, hazelnuts, Brazil 
nuts etc.), fish, vegetables (celery and other food of the Ombelliferae family), wheat and other 
cereals. Some food allergens can be destroyed by cooking or storage while others are resistant to 
such. Food processing and the introduction of new food technologies may help create allergens. 
5. The dose of food allergen required to induce an immunological reaction varies but in many 
instances is extremely low, particularly so for the life-threatening allergies. Accordingly, 
process contamination can introduce very low levels of an allergen to a food which in the case of 
certain allergies can be life threatening. This poses one of several problems for consumers who 
must read food labels because of their life-threatening allergic disorders. Such individuals are 
advised to be very circumspect about their use of processed foods. Problems also arise because of 
cross-reactivity of allergens. For example, patients with allergic reactions to inhalant allergens 
such as pollens may also become allergic to foods from plants other than those from which the 
inhalant pollen allergen originates. Allergies to latex are on the increase among health 
professionals because of increased haematological safeguards and contact allergy to latex may 
subsequently lead to allergic reactions to kiwi fruit, chestnut or banana. 
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6. The diagnosis of food allergy is difficult and may involve skin tests, food challenge, elimination 
diets and serum tests or combinations of all four and other possible approaches. In general, the 
diagnosis of food allergy involves extensive clinical consultation. Whereas widely publicised 
and simple procedures are available, treatment should only follow detailed clinical, 
immunological and dietetic investigations. 
7. Food additives have only seldom been found to cause food allergy, that is adverse reactions 
involving an immunological aspect. Non-immunological based food intolerance is more common 
place with food additives. Sulphite-induced asthma is well documented but eczematous and 
urticarial reactions to sulphite are also well documented although the exact mechanisms remain 
unclear. Adverse reactions have also been recorded with tartiazine and with non-azo colours, 
with aspartame, monosodium glutamate, benzoates and several other additives. However, the 
prevalence is quite low. 
8. Coeliac disease is an enteropathy due to an abnormal immune reaction to the wheat protein 
gluten. It may be considered as a form of food allergy but it is not IgE-mediated. The gluten-free 
diet remains the basis of the treatment, restoring health totally. 
9. Inherited metabolic disorders arise from a single gene defect which leads to a deficiency of an 
enzyme and in so doing creates a metabolic imbalance. For example, phenylketonuria (PKU) 
results from a mutation of the gene responsible for coding for phenylalanine hydroxylase leading 
to variable levels of phenylalanine in the blood. Dietary management to reduce phenylalanine 
intake is the only recourse for the management of the disease. 
10. The prevalence of food allergy and or food intolerance has been studied in only a few prospective 
studies in which the presence of food allergy is confirmed in double-blind, placebo controlled 
exposure studies. Studies of cow's milk allergy put the prevalence at 1 - 3%. A large Dutch study 
of 1483 adults found a prevalence of food intolerance of 2.4%. Two persons reacted to food 
additives giving a prevalence of 1.3 per 1000. Among 5000 adults studied in France only 1.3% had 
a positive skin test to one food type and of these only half suffered symptoms. A UK study of 7000 
households found that about 1 in 5 adults reported a food intolerance but with double-blind, 
placebo controlled challenge, the prevalence fell to 14 per 1000. Some 7.4% 'of the overall sample 
reported an adverse reaction to food additives but the level confirmed by double-blind, placebo-
controlled challenge was as low as 13 per 10,000. In a Danish study, 335 atopic children aged 4 -
15 years were questioned about hypersensitivity and 22.7% implicated food additives. An open 
challenge with food additives reduced this figure to 6.9% and a double-blind challenge reduced 
this further to 1.8%. A second and similar study investigated 173 children reporting 
hypersensitivity. In an open challenge with food additives 9.8% revealed a positive reaction 
while a double blind challenge of twelve of these positive children reduced the prevalence to 
3.5%. The combined results revealed a prevalence of 2% with open challenge and the double 
blind challenges would indicate the true prevalence of intolerance to food additives to be 1%. 
11. The prevalence of food allergy is highly dependent on geographical area. In areas where 
sensitivity to birch and mugwort pollen are prevalent, 30 to 50% of these patients present 
symptoms when ingesting fruits and vegetables. Thus, in these areas, the prevalence of food 
allergy in adults may be as high as 5 to 6%. The diet of a given country is also of importance. For 
example, peanut allergy was very common in the US but since this food has been widely 
marketed throughout Europe it is now a major allergen both in the US and Europe. Shrimp 
allergy is common in Southern USA, fish allergy is common in the Nordic countries and Japan 
because in these countries these foods are commonly ingested. It has been found that fish allergy 
may be as high as 3% in 3-year old Finnish children. 
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12. In conclusion, the true incidence of food allergy, while low and usually being under 1% of the 
population, is still such as to affect the lives of many people with conditions ranging from very 
mild to potentially fatal. 
Terms of reference 
Against the background of discussions in Codex Alimentarius and consultations between the 
Commission and Member States of the European Union on the question of labelling food ingredients to 
which some individuals may exhibit adverse reactions, the Working Group on Nutrition of the 
Scientific Committee for Food was asked to report on the subject paying particular attention to the 
following factors: 
the identity of those foods, food components and food ingredients which are associated with 
adverse reactions in consumers together with a characterisation of the adverse reactions 
concerned (adverse reactions in this context should include allergic reactions, reactions 
resulting from genetic and/or metabolic disorders and reactions of the type generally referred 
to as "intolerance"). 
the geographic distribution and frequency of adverse reactions within different sub-groups of 
the population of the European Union. 
the severity and significance for public health of the adverse reactions identified 
Background 
Individuals exhibit enormous variation in food preferences with factors such as taste, age, ethnic and 
cultural background, health beliefs and food availability all playing a role. In human nutrition, it is 
now widely held that a less-than-optimal balance of nutrients may contribute to an increased 
prevalence of risk factors for chronic disease. To that end, many efforts are being made to increase 
"health beliefs" as a significant factor in determining food preference. However, for very many 
individuals, the expression of a preference for a given food or of an aversion to another food on the 
basis of health beliefs is more likely to be associated with putative or true adverse reactions to 
specific foods or specific food ingredients than with risk factors for chronic disease. In public health 
terms, at the level of the population, a less-than-optimal balance of nutrients is a far more significant 
issue than that of putative or true adverse reactions to foods. In health terms, at the level of the 
individual however, adverse reactions to specific foods can be of considerable importance ranging from 
chronic suffering of non-life threatening conditions to the risk of sudden death. In this latter spectrum 
of conditions the adverse effects range from subjective psychological effects (depression, lethargy, 
anxiety) and subjective physical effects (nausea, headache, dizziness) to objective psychological 
effects (depression, hyperactivity) and to objective physical effects (urticaria, asthma, eczema etc.). 
The underlying cause(s) of these conditions with their origins in food or food ingredients also cover(s) 
a wide spectrum from unknown cause to causes arising from psychological, pharmacological, metabolic 
and immunological factors. 
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Against this background, the committee was concerned to consider the issue in the context of its 
significance in regulatory decisions relating to food labelling. Moreover, the committee did not confine 
itself largely to food additives as was the case in an earlier report of the Scientific Committee for 
Food (Twelfth Series). Thus, within the wide spectrum of adverse reactions to food real or imagined, 
the Committee, given its terms of reference, confined itself largely to the following health issues: 
Food allergy 
Adverse reactions to food additives 
Coeliac disease 
Inherited metabolic disorders 
However, other conditions were considered where, in the opinion of the Committee, they were of 
significant public health concern and at the same time were related to the issue of food labelling. In 
each section of this report consideration is given, where possible, to definitions, symptoms, diagnosis, 
foods and food ingredients implicated, prevalence and management. Prevalence of adverse reactions 
to food and food ingredients is considered as a separate section. 
In the case of defining prevalence, however, there are particular problems which merit consideration 
in this introduction. Because adverse reactions to foods can be clustered in distinct groups determined 
by occupation, geography, leisure activity, age, genotype and underlying health characteristics, 
average population prevalence rates may say little of the rate prevailing in the cluster of the 
population particularly susceptible to an adverse reaction to a food or food ingredient. Thus for 
example, it is not possible to say on a European Union basis, the likely average prevalence of an 
adverse reaction to a food where the food in question is consumed in a specific geographic region. 
Equally, to consider the overall population prevalence of, for example food, allergy may fail to take 
account of a much higher prevalence rate among atopic individuals, who, because of their disorder of 
the immunological system, suffer reactions to many environmental factors, from pollen to pets. 
Inherited metabolic disorders can be very rare in the European Union as a whole or in specified 
member states, but particularly high in nation sub-groups. For example, galactosaemia occurs with a 
frequency of 1 per 20,000 in Ireland but has a frequency of 1 in 700 of Irish Travellers. 
Case histories, while informative, do not assist in defining prevalence rates. Epidemiological surveys 
by questionnaire of representative samples regarding adverse reactions to food are also of limited 
value since they can only report perceived or putative adverse reactions to foods. Subsequent double-
blind placebo-controlled challenges may be the only way of verifying true adverse reactions to food at 
the level of the individual but are limited in estimating the prevalence of true adverse reactions to 
foods because not all individuals reporting in large surveys to be sensitive to a food agree to 
participate in a double blind challenge. This can be illustrated by a UK study which will be alluded 
to later in this report. Of 18,582 subjects who answered a postal questionnaire on perceived reactions to 
food and drink, 1372 (7.4%) reported problems with food additives. Of these 1,233 were invited to 
attend for a further oral questionnaire of which 649 agreed. However, only 81 of these were subject to a 
double-blind challenge of which three were positive, suggesting a true prevalence of 3 per 10,000. 
In reviewing this issue in the context of food labelling, the Committee was not asked to make specific 
recommendations but rather to prepare a document which might subsequently assist in regulatory 
decisions on food labelling. 
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Definitions 
For the purpose of this report, the following definitions apply: 
Adverse reactions: 
Represent a very wide spectrum of reactions to foods. 
Food intolerance: 
Non-psychologically mediated untoward reaction induced by a foodstuff, including food allergy. Non-
immunological reactions may be due to an enzyme deficiency, a pharmacological effect, or, as in the 
majority of instances, of unknown etiology (idiopathic). 
Allergy: 
A hypersensitive state acquired through exposure to a particular allergen, re-exposure bringing to 
light an altered capacity to react by an immune response. 
Atopy: 
The propensity, usually genetic, for developing IgE-mediated responses to common environmental 
allergens. 
Food allergy or food hypersensitivity: 
Untoward reaction due to an immunological mechanism induced by a foodstuff. 
Food aversion: 
Psychologically based food reactions with a conditioned response elicited by recognition of the 
appearance, smell or taste of a particular food. Aversion reactions do not occur reproducibly if the food 
is presented in a disguised form. However, many patients with food allergy develop aversion as a 
secondary psychological problem or because the food gives a bad tasted". 
Food induced symptom: 
Symptom caused by an adverse reaction to a foodstuff whatever mechanism is involved (immunologic 
and non-immunologic). 
Symptom with food allergy: 
Patient presenting a given symptom and an allergy to a foodstuff, but the causal relationship between 
food allergy and the symptom is not confirmed. 
Symptom due to food allergy: 
Patient presenting a symptom induced by a demonstrated food allergy. 
Incidence: 
The number of new cases diagnosed with the given disease in the population sampled during a given 
time period. 
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Prevalence at a given time: 
The number of subjects with the given disease in the population sampled without distinction between 
newly diagnosed and old cases. 
Cumulative prevalence: 
The number of subjects with the disease at any time during their life, whatever their health status at 
the time of the study. 
Food allergy 
Introduction 
Allergic or food hypersensitivity reactions are those that result from an immune event and represent 
in reality a group of distinct clinico-pathologic entities'
2). The best known example of such reactions is 
IgE-mediated food anaphylaxis but other types of hypersensitivity reactions have been linked to 
food allergy. As an example, reactions of delayed hypersensitivity also account for at least some of 
the intestinal problems which occur in coeliac disease'
3'. 
Food allergy has always posed a difficult problem, especially in adults. That food allergy exists can 
be readily demonstrated but some investigators continue to deny its existence whereas others tend to 
overestimate it. Non-allergic food intolerance is far more common than food allergy'
2' but the 
diagnosis of an allergic reaction to foods is often difficult. Life-threatening immediate reactions 
appear to be rare but are apparently increasing in prevalence and are usually easily diagnosed, 
whereas reactions which cannot be related to an obvious immune response are far more common. 
It is not clear whether food allergy is increasing in prevalence as has been observed for inhalant 
allergy. The recent introduction of new allergens such as kiwi, papaya and mango has lead to the 
generation of new food sensitivities that were unknown a few years ago. The processing of food may 
enhance the allergenicity of a given food but little is known. New technologies'
4' are allowing the 
food industry to develop products from standard foods which may not be recognized in their modified 
form by food allergic patients or may become allergenic in previously non-sensitized patients'
5'. 
Special attention should also be paid to novel foods or novel food ingredients i.e. foods which have 
not hitherto been used for human consumption to a significant extent and/or which have been produced 
by extensively modified or entirely new food production processes'
6'. 
Symptoms of food allergy 
Food allergy can elicit almost any allergic symptom and sign but some are more common and more 
widely demonstrated'
7'. Symptoms can occur immediately after the ingestion of the offending food 
(acute urticaria or anaphylaxis) but they may be delayed several hours in the case of atopic 
dermatitis. Patients may present a single symptom but often there is a multi-organ involvement, 
including cutaneous, respiratory, gastrointestinal and ocular reactions. In particular, most patients 
with asthma due to food allergy present an atopic dermatitis'
8'. 
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The link between food allergy and the occurrence of adverse reactions is well established for a number 
of these symptoms. This is the case with urticaria / angioedema and (more rarely) chronic 
urticaria'
9', atopic eczema (atopic dermatitis is more often caused by food allergy in children than in 
adults'
10', conjunctivitis, laryngeal oedema, Lessof's syndrome'
11', acute gastrointestinal reactions 
following the ingestion of specific food'
8·
12' and of course asthma'
13'. Anaphylactic reactions, 
eventually causing death, and exercise-induced anaphylaxis'
14"
16' are also as a general rule easily 
attributed to food allergy. 
Food aversion is often claimed by patients with food allergy but care should be taken to avoid a 
positive diagnosis of food allergy in many such patients in whom aversion is not due to allergy'
17'. On 
the other hand, food allergy has been rarely demonstrated in "hyper-reactivity" and tension-fatigue 
syndrome'
18', in dysuria, arthritis'
19' and in a series of poorly defined digestive symptoms including 
protein-losing enteropathy. Food allergy was also supposed to be a major cause of migraine'
20' but, 
when the appropriate tests were performed it was observed that food allergy was rarely involved'
21'. 
Food allergens 
Almost any food can induce an allergic reaction. However, some foods are more commonly allergenic 
although the prevalence of sensitization depends on regional diets and cross-reactivities with 
inhalant allergens. 
Cow's milk 
Cow's milk protein allergy is relatively common in infancy. It occurs in up to 2% of infants but its 
prevalence decreases with age. Allergy to cow's milk is mainly an IgE-mediated allergic reaction but 
other immune mechanisms have been identified'
22'. Although developing usually during early 
infancy, allergy to cow's milk may be acquired later in life. Allergic reactivity to cow's milk is lost 
during childhood in the vast majority of cases. IgE and challenge tests show that most cow's milk-
allergic patients react to several protein fractions of cow's milk including casein, alpha-lactalbumin, 
and ß-lactoglobulin'
23'. Patients may react to one or more of several protein fractions of cow's milk and 
the range of reactions will differ from patient to patient. This will also account for the variation in 
sensitivity to different diary products, for which the method of preparation may reduce or enhance 
the allergenicity of raw cow's milk. 
All major cow's milk proteins in native form are potential allergens in subjects with cow's milk 
allergy. The allergenicity of cow's milk can be reduced by different treatments'
24'. Enzymatic 
hydrolysis cleaves the polypeptide chain at specific sites, which leads to the breakdown of the 
antigenic architecture of the molecule and causes a progressive disappearance of its allergenic 
properties, including epitopes resulting from its amino acid sequence if the duration of hydrolysis is 
sufficient'
25'. The a- and ß-caseins, ß-lactoglobulin and α-lactalbumin are highly sensitive to 
enzymatic hydrolysis by endopeptidases, such as trypsin and chymotrypsin. On the other hand, κ-
caseins, bovine serum albumin and immunoglobulins are quite resistant to this process when directly 
applied to their native structure, and a combination of hydrolysis and thermic treatment may be 
necessary'
26'. Heat treatment destroys heat-labile milk proteins (bovine serum albumin and 
immunoglobulin) and changes the antigenicity of other whey proteins (ß-lactoglobulin) but it has 
virtually no effect on the antigenicity of casein'
27·
28'. However, even for whey proteins, the thermic 
shock necessary to reduce significantly protein allergenicity would induce a Maillard reaction and 
their nutritional value would be reduced to an unacceptable extent'
29'. Heat treatment alone is 
therefore unable to provide a good quality "hypoallergenic" formula, but the combination of selective 
hydrolysis and heat treatment has been used to prepare partly hydrolysed formulae without 
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decreasing the nutritional value of whey proteins'
26'. Filtration can also be applied to remove 
remaining high molecular-weight peptides and residual proteins, and some ultrafiltrated whey 
hydrolysates have been developed'
30'. 
The therapeutic efficacy of semi-elemental diets for treating proven enteropathies related to cow's 
milk proteins or anaphylactic reactions triggered by milk products or other dietary proteins is well 
established. Most studies were carried out with highly processed casein hydrolysates. The positive 
effect of these extensively hydrolysed preparations in children with cow's milk allergy was largely 
documented'
25·
29'. However, confirmed cases of allergenic reactions were reported, implying that a 
risk for general reactions always exists when providing any hydrolysed product to subjects highly 
reactive to cow's milk. Moreover, skin prick tests with undiluted hydrolysate formulae are often 
positive in such patients, but positive skin test with hypoallergenic formulae do not correlate 
necessarily with symptomatic reactivity, suggesting that skin prick tests alone are not indicative of 
hypersensitivity to extensively hydrolysed formulae'
31·
32'. The efficacy of extensive whey-protein 
hydrolysates, or of a mixture of soya proteins and beef collagen, has also been demonstrated in infants 
with cow's milk allergy'
25·
33', and anaphylactic reactions to these highly processed hydrolysates 
infrequently reported'
34·
35'. Using double-blind, placebo-controlled food challenges in documented 
cow's milk allergic subjects, three of these extensively hydrolysed preparations (two casein-based 
and one ultra filtered whey-based formula) were proven "hypoallergenic"'
29·
3" according to the 
guidelines of the Subcommittee of Nutrition and Allergic Diseases of the American Academy of 
Pediatrics'
36'. 
Only extensively hydrolysed preparations can be recommended for the treatment of cow's milk 
allergy, owing to their overall proven safety and hypoallergenicity. The partly hydrolysed whey 
formulae, which contain a number of unresolved proteins on high density SDS-PAGE and non-
degraded whey proteins in the molecular range of 1 to 20 kD'
31' can cause allergic reactions'
35·
37'. 
Consequently, partly hydrolysed formulae should be avoided in allergic infants'
25·
38'. 
Other common food allergens 
Among, the major sensitising foods are fruits, legumes (especially peanuts and soybean), eggs, 
crustaceae (shrimps, crab, lobster and crayfish), tree nuts (almonds, walnuts, hazelnuts, Brazil nuts 
etc.), fish, vegetables (celery and other foods of the Ombelliferae family), wheat and other 
cereals'
39"
41'. 
The allergenic activity of some food allergens is destroyed by heating or during storage (e.g. in 
apples'
42') whereas others are resistant to denaturing including cooking and digestion (casein, egg and 
fish antigens). 
The problem of trace amounts of allergenic foods in processed foods is a matter of unresolved concern. 
This deserves further investigations since although very rare, trace amounts of allergenic proteins can 
be found as contaminants in foods such as oils'
43'. The method of preparation of foods is directly 
involved in such contaminations. Considerable effort should be made to develop highly sensitive tests 
which will identify allergens in foods so that it may become possible in the future for manufacturers 
to safely label products as being devoid of, or at least sufficiently free of, products not to cause a 
significant problem for allergic individuals. However, until such testing is in place, food allergic 
individuals should be advised to be very circumspect about their use of processed foods. 
A major problem of food allergy is the presence or absence of low amounts of a given food allergen in a 
processed food. Although it is relatively easy to include in the label the presence of a food allergen 
when it is one of the components of the food, it does not seem realistic and may even be dangerous to 
label a food as "devoid of..." because trace amounts of allergens can always be present, and their 
content may differ depending on the processing. 
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Food allergens which cross-react with inhalant allergen 
Patients with allergic rhinitis/conjunctivitis to birch and to a lesser extent to other Betulaceae 
(hazel, alder) pollen are frequently hypersensitive to nuts, fruits including apple, carrots and 
potatoes'
44·
45'. Most patients present mild symptoms but anaphylaxis may occur with these cross-
reacting foods. Some birch or hazel pollen allergens cross-react with those of apple, other fruits (™) or 
various nuts'
47'. Most of the patients with food hypersensitivity are those with a severe allergy to 
pollens'
44'. Some Compositeae pollen allergens (mugwort) cross-react with foods of the Ombelliferae 
family (celery in particular)'
48'. Although IgE fractions to food allergens are highly prevalent in 
patients allergic to Betulaceae and Compositeae pollens, only a proportion of these present symptoms 
of food allergy'
49'. Ragweed (Ambrosia pollen) sensitive individuals may get symptoms when earing 
banana or melon. 
Allergy to latex has been booming recently because of the overwhelming use of latex gloves by medical 
and paramedical professionals'
50' and its extensive use in many appliances such as catheters. Cross 
reactive antigens have been identified between latex and banana, chestnut or kiwi fruit'
51'. 
Diagnosis of food allergy 
Although most immune mechanisms may induce a food allergic reaction, besides coeliac disease, the 
IgE-mediated allergic reaction is more easily diagnosed than others. The diagnosis of food allergy is 
difficult because allergen extracts currently available are not standardized, and their stability is 
poorly determined'
52'. For allergen extracts that are rapidly degraded like those of fruits and 
legumes, skin tests may be falsely negative in food allergic individuals. Even more so than in 
inhalant allergy, the presence of food-IgE in serum or a positive skin test to a foodstuff does not 
always correlate with a food allergy since (i) many patients outgrow their allergy with age'
53·
54' and 
(ii) not all patients with food-specific IgE have a clinical sensitivity. In many instances the diagnosis 
has to be confirmed by a double-blind food challenge that should be carried out under precisely 
specified conditions and by trained investigators. As for other forms of food allergy, unproven and 
controversial techniques such as cytotoxic tests or sublingual provocation tests have absolutely no 
value. 
Patients who develop acute urticaria or anaphylaxis often make the diagnosis of "food intolerance" 
by themselves and the presence of positive skin tests and/or serum specific IgE correlating with the 
claims of the patient makes a diagnosis possible without performing a food challenge. This test may 
cause severe untoward reactions in patients with anaphylaxis and therefore should not be done. 
However, for many other symptoms including asthma, patients rarely incriminate a food as the cause 
of wheezing so (i) it is necessary to suspect a food allergy and (ii) to confirm the diagnosis by double-
blind food challenges'
55'. 
Anamnesis 
The diagnosis of food allergy should always begin with a detailed clinical history. However, a 
variety of toxins may produce symptoms that appear indistinguishable from immediate 
hypersensitivity reactions. These include scromboid, histamine and ciguaterra poisoning'
8'. 
Reports of the Scientific Committee for Food (Thirty-seventh series) 22 SEPTEMBER 1995 ADVERSE REACTIONS TO FOODS AND FOOD INGREDIENTS 
Skin tests and serum specific antibodies: 
The performance of skin prick tests with food allergens is the second step of the diagnosis. If possible, 
positive skin tests should be confirmed by the titration of serum specific IgE. Some investigators prefer 
to use intradermal skin tests but although they were shown to be slightly more sensitive than skin 
prick tests, they also cause more non-specific positive reactions and may induce systemic reactions. 
Extracts made from fruits and vegetables are usually of poor quality since the allergens are rapidly 
destroyed and skin tests with fresh foods are more accurate'
56'. A positive skin prick test and/or serum 
specific IgE should not preclude the use of a food challenge since only one third of patients presenting 
with positive skin prick tests and/or serum specific IgE have asthma during food challenge'
55·
57·
58', 
and, many patients outgrow their clinical allergy but retain skin test reactivity. A diet should not 
therefore be started before food challenges have been performed. The titration of serum food specific 
IgG or of its subclass IgG^ is useless in the diagnosis of food allergy. 
Food challenge 
Food challenge is an important diagnostic tool not only for supporting a diagnosis, but, also to identify 
that a person is not allergic, thereby avoiding an unnecessary expensive intrusive diet which may 
have nutritional consequences. Food challenges should be performed in a manner similar to that 
reported by Bock'
59', or Sampson et al '
57'. The food suspected as causing symptoms should be 
eliminated from the diet for a minimum of 2 weeks before testing. Although patients who had 
presented anaphylactic symptoms should not be tested, it is advised to start with a very small dose 
and increase them slowly and carefully. Challenges should preferably be conducted in a double blind 
manner, but if several food stuffs are incriminated, screening with single blind challenges may be 
carried out first. In case of food-induced asthma, a series of pulmonary function tests should be 
conducted for up to 8 hr following challenge since late reactions can occur'
55'. Bronchial 
hyperresponsiveness to methacholine or histamine may be measured before and after challenge. For 
eczema, some scoring systems have proven their value (SCORAD) in assessing the response. For 
overall symptoms, Young et al have developed a combined clinical score that may be used'
60'. During 
all challenges a physician should monitor the patient since some untoward systemic reaction might 
occur. 
Food challenges may be improved by measuring the release of mediators in peripheral blood'
61' or the 
increased gut permeability'
62' or assessing the response by gut mucosal biopsies. The measurement of 
non-specific bronchial responsiveness before and after an oral challenge may enhance the 
interpretation of oral challenge in asthmatic subjects in that some patients only develop an increase of 
bronchial responsiveness to histamine after a food challenge without any change in baseline peak 
flow. 
A positive food challenge, indicative of food intolerance, does not necessarily imply that the patient 
presents an IgE-mediated allergy. If specific IgE and/or prick tests to this food are positive, an IgE-
mediated mechanism is likely to be involved. Only one quarter to one third of patients with positive 
skin tests and/or specific IgE have a positive oral challenge. 
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Elimination diets 
Elimination diets tend to be nutritionally unsound and must be supervised very carefully by fully 
qualified dieticians. They are primarily used for the diagnosis of chronic diseases such as eczema, 
asthma and rhinitis. The results of elimination diets are difficult to interpret because many children 
with genuine food allergy, even if symptoms were severe, have only a transient problem. One study of 
323 patients with chronic allergic rhinitis revealed 21 who had improvement on a cow's milk free 
diet and relapse on open challenge. However, only two of the 21 reacted on subsequent double-blind 
challenge'
63'. 
In the case of asthma, it is even more difficult to make the diagnosis of food allergy by elimination 
diets for many reasons: (i) food allergy is almost constantly associated with inhalant allergy and 
possibly with other triggers, and variations in the airways obstruction may be due to factors unrelated 
to foods, (ii) food allergens as well as inhalant allergens aggravate the non-specific bronchial 
hyperreactivity and it may take days or even weeks to observe an improvement of asthma, and (iii) 
the great variability of the airways obstruction in patients with chronic asthma may mask the 
benefits of dietary manipulations. However, when a patient is highly allergic to a given food, 
significant improvement or even complete remission can be observed. 
Natural history of food allergy 
Most cases of food allergy are observed in early infancy and are often related to hypersensitivity to 
cow's milk. The prevalence of food allergy peaks in children and decreases with age. Differences in 
disappearance rate depends on the allergen and on individual factors'
22·
53·
54·
64"
67'. Most children with 
cow's milk allergy tolerate at least small amounts of cow's milk at 3 years of age. Egg allergy usually 
subsides before puberty but if it has started early or if atopic symptoms are severe, allergy tends to 
persist. On the other hand, allergy to fish, shellfish, nuts and peanut does not disappear in most 
patients although it may be less severe. 
Clinical management of food allergy 
The presence of a positive skin prick test or serum specific IgE to a given food should not lead to an 
elimination diet because only 30 to 40% of patients have a chronic symptom like asthma or rhinitis 
when they are challenged orally with the offending food. A positive food challenge favours dietary 
avoidance but the nutritive value of a diet must always be maintained, especially calcium intake for 
cow's milk avoidance'
68'. Also, the reintroduction of a food, accidental or intentional, may cause 
anaphylaxis or severe respiratory obstruction since individual patients tend to continue to react with 
the same symptoms as they had before. In case of cow's milk allergy, contrary to popular belief, sheep 
and goat milk are not suitable alternatives as they are equally likely to produce allergic reactions 
due to cross reactivity'
69'. Finally, it has been proposed to reduce allergenicity of foods by removing 
potent allergens'
70' or by hydrolysing the foodstuffs'
33·
37·
7". The efficacy of medications has been 
demonstrated in some but not all trials. 
There is no evidence at present to support specific immunotherapy by either the oral or the parenteral 
route except for research purposes and it must be pointed out that this form of treatment may lead to 
severe untoward reactions'
72'. 
In any case, the treatment of the symptom(s) is of importance. Due to the severity of the reaction 
anaphylaxis should be treated immediately using adrenalin and emergency measures if required. 
Asthma is a disease of the airways and patients should always have a treatment of the bronchial 
inflammation and obstruction besides the treatment of food allergy. Skin symptoms also require 
specific treatment. 
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Prevention of food allergy is a difficult matter and although a large number of studies have been 
carried out, there are no convincing data demonstrating the efficacy of interventions. There is much 
evidence that the development of allergic disorders may be related to early exposure to allergens, 
including those in breast milk of maternal dietary origin. Breast feeding is strongly advocated by 
paediatricians but it is not yet known whether it can prevent the onset of allergy to cow's milk or it 
only delays the onset of allergic symptoms. Moreover, although the effect of breast feeding has been 
observed in delaying the onset or reducing the severity of atopic dermatitis, no evidence of any effect 
was found on asthma or later allergic disorders'
73·
74'. Allergenic foods including cow's milk can be 
found in breast milk and these foods can induce an IgE-mediated senstization of the new-born'
75'. 
Mothers reducing ingestion of highly allergenic foods during breast feeding may improve the 
preventive efficacy of breast feeding but data are conflicting'
76·
77'. "Hypoallergenic" infant formulae 
may also be preventive but more data are needed to better evaluate their real value'
33·
37'. Finally, it 
seems appropriate to delay for a period of four to six months the introduction of solid foods which 
may sensitise new-boms and young infants'
78,79'. However, the cost-benefit and quality-of-life effects 
of such interventions have not hitherto been subjected to any prospective study. 
Adverse reactions to food additives 
Introduction 
There are many agents that are intentionally added to the food that we consume. These include 
preservatives, stabilisers, conditioners, thickeners, colourings, flavourings, sweeteners, antioxidants, 
etc. Yet, only a surprisingly small number have been associated with hypersensitivity reactions but 
there is ample evidence that food additives of several sorts may precipitate adverse reactions'
80'. 
Only seldom have food additives been shown to cause true allergic (immunological) reactions. 
Adverse effects due to various pharmacological or other mechanisms are much more common'
8". Many 
patients suffering from food additive reactions have atopic constitutions and such clinical symptoms 
as atopic dermatitis, rhinitis and asthma'
82·
83'. Some of the adverse reactions may be fatal such as 
sulfite sensitivity in asthmatic patients but reactions to other food additives are unusual and less 
severe. The most important skin symptoms caused by food additives are urticaria, angioedema, and 
contact urticaria. Hypersensitivity reactions in organs other than the skin and respiratory tract are 
rare or poorly documented. While popular belief has it that additives may have harmful 
behavioural effects, and despite a large number of studies which have evaluated the role of food 
additives in hyperkinesis, results are not uniform. Some studies have suggested that there was some 
link between food additives and hyperkinesis'
84·
85' but when the studies have been more carefully 
carried out the demonstration of such interaction was not confirmed'
86'. Evidence does suggest that 
there is a very small subset of primarily younger children in whom additives will impact on 
behaviour'
87·
88'. Psychological factors play an essential role in both food and food additive 
reactions'
1'. 
Suspected food additive sensitivities are best documented by oral challenges, preferably in a double-
blind placebo-controlled manner since many patients react under placebo'
89'. Challenges in asthmatic 
patients need to be done with patients continuing on their routine medications to avoid false positives. 
All care should be taken to titrate the doses and schedule the doses appropriately, since several of 
these agents could provoke large reductions in pulmonary function. With urticaria patients, an 
adequate baseline of urticaria activity needs to be established before the challenges so that 
fluctuations in normal activity are not construed as a positive result. As with asthma, the problem 
appears to be much smaller than originally postulated'
90'. 
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Restricted diets are of no general benefit in asthmatic patients: In contrast to asthma, in urticaria or 
other cutaneous reactions to food additives, a restricted diet for a few months' duration may be 
beneficial, although the mechanism through which this is achieved is unclear'
90'. However, food 
additive avoidance is often difficult to be carried out since not all additives may be labelled and 
when intolerant patients are eating in a restaurant it is impossible to determine which additive is in 
the food ingested. 
Intolerance to sulfites 
The term sulfiting agents is used to describe sulfur dioxide (S02) and several inorganic sulfites (sodium 
sulfite, potassium bisulfite and metabisulfite) that may be added to foods, beverages and 
pharmaceuticals. Sulfiting agents are used to control microbial growth in fermented beverages and 
have been widely used in the food and beverage industry for over 2,000 years. They have been shown 
to frequently trigger attacks of asthma'
80' and more rarely other symptoms. Sulfites are also used in 
drugs and those administered by inhaled route have caused several asthmatic reactions'
91'. Moreover, 
it seems that dental local anaesthetics preserved with sulfites have induced asthma in some 
patients'
92'. 
Despite the increasing amount of data that has accumulated on sulfites as the intensity of medical 
interest has expanded in recent years, there are lingering, difficult, and, in most cases, as yet 
unresolved questions about sulfite sensitivity. These include questions about mechanism of action, 
prevalence and the most effective methods for protecting sulfite-sensitive patients from exposure to 
sulfites'
93'. 
Mechanisms of sulfite intolerance 
The exact mechanism of sulfite sensitive asthma is unknown but most likely involves hyperreactivity 
to inhaled S02 in the great majority of cases'
80', however, there are reports of IgE mediated 
reactions'
94' and other sulfite sensitive asthmatics have been found with low levels of sulfite 
oxidase'
95'; necessary to oxidise endogenous sulfite to sulfate. It is possible that patients with sulfite-
induced urticaria present more commonly an IgE-mediated reaction. 
Sulfite-induced asthma 
Most patients with sulfite-asthma have severe chronic asthma, often corticosteroid-dependent'
80'. 
Usually, but not always, the patient is non-atopic but may suffer from chronic vasomotor 
rhinosinusitis. These individuals are differentiated from aspirin-sensitive asthma because they lack 
nasal polyps and eosinophilia. However, some aspirin sensitive asthmatics present also a dyspnoea 
after ingestion of wine or foods containing sulfites'
96·
97'. Fatal asthma has been reported after 
ingestion of sulfite-containing foods or drinks. There is no link between sulfite sensitivity and the 
degree of airways hyperresponsiveness'
98'. 
Due to the lack of reliable skin or in vitro tests, the diagnosis of an intolerance to sulfites is still based 
on placebo-controlled oral provocation tests. Sulfite-challenge may cause a severe asthmatic reaction 
so it should be carried out by trained investigators and when the patient is in a stable state. 
A screening challenge should be conducted in a single-blind, open fashion, and when positive, 
confirmed by a double-blind challenge'
99'. Doses of ingested sulfites should be increased cautiously. 
However, sulfite-sensitive subjects with asthma will not necessarily react after ingestion of sulfited 
foods. The likelihood of a reaction is dependent on the nature of the food, the level of residual sulfite, 
the sensitivity of the patient, and perhaps on the form of residual sulfite and the mechanism of the 
sulfite-induced reaction'
100'. 
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Other symptoms 
Delayed eczematous and immediate urticarial reactions due to sulfites in foods have been 
demonstrated'
101·
102). However, sulfites represent a rare cause of urticaria"
03'. Anaphylaxis-like 
reactions are exceptionally caused by sulfites'
104'. Clinical cases of contact allergy due to sulfites 
have been observed'
105'. 
Intolerance to other food additives 
Tartrazine, azo and non-azo food colours 
All food colours contain aromatic rings and some contain azo-linkage. Tartrazine, sunset yellow and 
carmoisine are the most widely used azo food colours. Non-azo food colours include brilliant blue, 
erythrosine and indigotin. Although azo and non-azo food colours have been implicated in a number of 
anecdotal hypersensitivity reactions, it has been concluded that they are rarely involved'
106"
108'. 
Following the study of Samter and Beers, for many years, tartrazine was thought to cross-react with 
aspirin and to cause asthma'
109'. However, it has now been demonstrated that tartrazine is not a 
cyclooxygenäse inhibitor'
11(" and several double-blind placebo-controlled challenges with tartrazine 
in aspirin-intolerant asthmatics have led to the conclusion that there was no cross-reactivity between 
cyclooxygenase inhibitors (aspirin and nonsteroidal anti-inflammatory agents) and tartrazine'
108'. 
Tartrazine may cause asthma by itself but such a reaction is, at most, rare'
1"·
112'. Tartrazine can 
however cause urticaria, atopic dermatitis or hyperkinesis in an occasional patient but their 
prevalence is again very small'
108·
113'. 
Aspartame 
Aspartame is a food additive used as an intense sweetener. Neurologic, gastrointestinal, and allergic 
reactions have been reported but very few have been eventually confirmed'"
4·
115'. Aspartame will be 
further discussed under the section on metabolic disorders (section 6). 
Monosodium glutamate 
Monosodium glutamate (MSG) is one of the most widely used food additives around the world. It has 
been involved in the "Chinese restaurant syndrome" which consists of the development within hours 
after a meal of headache, burning sensation along the back of the neck, chest tightness, nausea and 
sweating'"
6' and in delayed airways obstruction'"
7'. The prevalence of this syndrome was as high as 
30% in some studies. However, double-blind challenge of individuals who identify themselves as 
suffering the 'syndrome' has often failed to confirm the role of monosodium glutamate as the 
provocative agent, and, when some common food materials are used in the same experimental setting, 
similar symptoms can be produced in a limited number of people'"
8'. Moreover, it has been observed 
that the occurrence of urticaria, angioedema or anaphylaxis after meals in Chinese or Indonesian 
restaurants is more often due to IgE-mediated Type I food allergy, caused by consumption of shrimp, 
peanut or spices, or herbs in particular those of the parsley family (e.g. coriander)'"
9'. Finally, 
glutamate sensitivity is exceptionally occurring in asthmatics'
120'. 
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Benzoates and esters of para-benzoic acid 
Benzoic acid and sodium benzoate are widely used as antimycotic and antibacterial preservatives in 
foods and beverages. Esters of parabenzoic acid (parabens), are also used as preservatives in a limited 
number of foods. Adverse reactions to these compounds in patients who suffer from chronic urticaria 
have been extensively studied. It is clear that benzoates in foods can cause urticaria in adults (for 
review see:'
121·
122') and in children'
123'. However, double-blind placebo-controlled challenges have 
been rarely carried out and the exact prevalence of benzoate intolerance in chronic urticaria is still 
unknown, ranging from almost none to over 50%. These differences may be explained (i) by the 
difficulty to perform reliable challenges and interpret them'
124', (ii) by the inability of many 
patients to confirm the positivity of the challenge by an effective benzoate-free diet , and, (iii) are 
also related to the day-to-day variability of symptoms. 
The prevalence of hypersensitivity to benzoates in asthma is unknown since of the few studies that 
have been conducted, most were not adequately carried out. However, it is likely that benzoates are 
rarely inducing asthma'
106·
125'. 
Parabens have been shown to elicit IgE mediated hypersensitivity reactions when used as 
pharmaceutical preservatives; however, as with the other additives noted above, ingested parabens 
have only occasionally been associated with adverse reactions'
122'. 
Other additives 
Although any food additive may induce an untoward reaction, anecdotal reports confirmed by 
challenge have found some particular reactions. Two cases of chronic urticaria were found to be 
exacerbated by the antioxidant food preservatives, butylated hydroxyanisole (BHA) and butylated 
hydroxytoluene (BHT)'
126'. 
Some allergenic enzymes from Aspergillus or other sources have been identified in flour and were 
shown to cause asthma in bakers but there is apparently no food allergy described. 
Coeliac disease 
Definition 
Coeliac disease is an enteropathy due to an abnormal immune reaction to gluten. It may be considered 
as a form of food allergy although it is not IgE mediated. 
Pathophysiology and genetics 
There are evidences suggesting that the characteristic hyperplastic villous atrophy is secondary to 
an abnormal T-cell mediated response to gliadin, the alcohol soluble fraction of gluten, (and to 
related prolamines from rye, barley and oats) whose peptides (α, β, γ and ω) contain 'toxic' sequences 
(Pro-Ser-Gln-Gln, Gln-Gln-Gln-Pro). This abnormal response occurs in genetically .susceptible 
individuals, bearing in their vast majority (> 90%) the major histocompatibility complex (MHC) DQ 
(a*0501, ß,'0201) heterodimer'
127'. In these individuals, some CD4
+T cells located in the lamina 
propria may initiate the pathological process leading to villous atrophy with increased 
intraepithelial CD8
+ and γ/δ TCR
+T lymphocytes. 
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Features 
Although the onset of the disease occurs more commonly in children, nevertheless, adult onset coeliac 
disease also occurs. In toddlers, coeliac disease remains characterised by a classical malabsorption 
syndrome with loss of appetite, diarrhoea, loss of weight, abdominal distension, and finally growth 
retardation. The older the child, the less symptomatic the disease which may manifest merely as 
short stature in a teenager. Usual blood tests (RBC count, levels of plasma iron, folate, cholesterol, 
vitamins A and E) may be useful to show the nutritional consequences of malabsorption'
128'. 
Adults usually present with anorexia, abdominal pain, diarrhoea and weight loss; but some present 
with unsuspected sideropaenic anaemia, folate deficiency, osteomalacia or depression'
129'. 
The disease may be silent and should be looked for among first relatives of patients, in patients with 
diabetes (prevalence - 3%), IgA deficiency, IgA nephropathy, dermatitis herpetiformis and other 
immune mediated diseases'
130'. 
Methods of investigations 
Although one hour blood xylose test, and permeability tests may be helpful in indicating a proximal 
intestinal lesion, the best single test to perform before an intestinal biopsy is the assay of the anti-
gliadin, -reticulin, or -endomysium IgA and/or IgG antibodies. When the three tests are performed 
together the positive predictive value of these antibodies is near 100%. Finally, the diagnosis rests 
on the intestinal biopsy which shows the characteristic hyperplastic flat mucosa'
128'. 
Management 
The gluten free diet remains the basis of the treatment, restoring health totally. It is usually a life 
long prescription. It has been shown in an English cohort that gluten free diet might decrease the risk 
of malignancies and particularly lymphoma in adults who adhere to it during more than 5 years'
13". 
The increased risk of malignancies, well shown in several former American, English and Swedish 
series, is not found in a recent Finnish study concerning adult patients supposedly following a gluten 
free diet in the proportion of 85%"
32'. 
Inherited metabolic disorders 
Introduction 
Over 300 human diseases due to inborn errors of metabolism are now recognized, and this number is 
constantly increasing as new concepts and techniques become available. Until recently certain of these 
hereditary metabolic disorders (and in particular overload disorders) were untreatable. Progress 
made in (bone) marrow transplants or enzyme replacement therapy have, however, enabled 
encouraging results to be obtained in certain cases and high hopes are being entertained for gene 
therapy in order to compensate for enzyme deficits where no other form of treatment is available'
133'. 
For many of the inherited metabolic disorders there is some scope for dietary management, whether 
this involves removing a source of carbohydrates from the diet (e.g. galactose in galactosemia or 
fructose in fructosemia), reducing fat intake as in certain fatty-acid-metabolism disorders, reducing 
overall protein intake, or specifically restricting the intake of certain essential amino acids (e.g. 
phenylalanine in phenylketonuria or branched-chain amino acids in maple syrup urine disease, 
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methylmalonic acidemia or propionic acidemia). The use of pharmacological doses of thiamine, 
pyridoxine or biotin may also constitute an effective treatment for vitamin-dependent disorders 
where the mutation in question affects the link between an enzyme or receptor with its co-factor'
133'. 
Three inherited metabolic disorders are to receive special attention as part of food intolerance owing 
to the ubiquitous nature of the nutriments involved, their toxicity for the sufferers of deficits and, 
consequently, of the need to inform patients or their families of the presence or otherwise of these 
components in prepacked foods. Those disorders are phenylketonuria, galactosemia and fructose 
intolerance. 
Lactose intolerance, which is very widespread among certain ethnic groups, is not as a rule due to á 
structural anomaly in a gene as in exceptional congenital lactose intolerance, but to deficiency of 
lactase synthesis after weaning, as normally occurring in practice in all mammalian species in which 
lactose is the main sugar in their milk'
134·
135'. It therefore does not strictly count among the innate 
metabolic malfunctions. The problems thus caused for victims are, moreover, of quite a different type 
since they manifest themselves via signs indicating intestinal fermentation (swelling, abdominal 
pains, or even diarrhoea) where excess lactose is ingested, but not via toxicity to the liver and/or 
brain as in the case of galactose, fructose or phenylalanine in patients suffering from galactosaemia, 
hereditary fructosemia or phenylketonuria respectively. 
Phenylketonuria 
Phenylketonuria (PKU) is caused by the mutation of the phenylalanine hydroxylase gene which 
suppresses the activity of the enzyme either fully (or almost so). More than 200 mutations have been 
recognized'
136' which to varying degrees affect synthesis of the enzyme, its stability or catalytic site. 
A random distinction can be drawn between three types, which differ via the degree of enzyme 
deficit, and whose repercussions on mental development are not the same: (i) classic PKU whereby the 
residual activity of the liver is less than 1% of normal, and which manifests itself via an increase in 
the level of plasma phenylalanine, upstream of the block, above 1.2 mmol/1 (20 mg/100 ml) and a 
tolerance of less than 350-400 mg of phenylalanine/day in the diet; (ii) mild PKU whereby 
phenylalanine hydroxylase activity of roughly 1-3% persists and which is characterised by a 
phenylalaninemia lying between 0.6 and 1.2 mmol/1 (10-20 mg/100ml) and a tolerance lying between 
100 and 750mg of phenylalanine/day; (iii) moderate permanent hyperphenylalaninemias which 
corresponds to residual activities of more than 5% of the normal and whereby, by definition, the 
phenylalaninemia does not exceed 0.6 mmol/1 (10 mg/100 ml) when a normal diet is followed. Where 
there is no neonatal screening and early treatment, only classic and mild PKUs involve a risk of 
mental retardation. The frequency of these forms to be treated varies within the European Union. The 
estimates are 1/4 500 in Ireland, 1/8-10,000 in Denmark, 1/10,000 in Belgium and 1/16,500 in 
France(136-138). 
Phenylalanine represents, on average, 4-5% of the amino acids in all food protein. A normal diet (2-3g 
of proteins/kg bw) thus supplies roughly 1250mg to a one-year old child and almost twice this in a 
five-year old child, whereas the tolerance of the victims, which only increases very slightly with 
age, is several times lower than these values in the most severe cases. This situation demands the use 
of amino acid mixtures that contain no phenylalanine, but which are tyrosine enriched (tyrosine is 
essential in the absence of phenylalanine), or of protein hydrolysates from which most of the 
phenylalanine has been removed, for example by means of adsorption on activated charcoal. The 
nitrogen requirements and those for the other essential amino acids may thus be met, and the 
phenylalanine that is necessary for growth is basically obtained from fruits and vegetables. 
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Restriction of phenylalanine intake in amounts which enables the phenylalanine plasma level to be 
kept below 0.4 mmol/1 (7 mg/100 ml) throughout life, or at least until adolescence, allows normal (or 
quasi normal) physical and intellectual development to take place in the children afflicted'
138·
139'. 
Aspartame which is a dipeptide made up of aspartic acid and phenylalanine is used as an intense 
sweetener to substitute sucrose in a whole range of "light" beverages and low-calorie products (e.g. 
yoghurts). It may constitute a significant source of phenylalanine for patients and prevent 
satisfactory checking of their rate of plasma phenylalanine'
140·
141'. It is therefore important that 
they be informed of this, and it would be highly desirable for an appropriate warning to have to be 
entered on the labels for food products containing these, as is already the case in certain Member 
states. 
Fructosaemia 
Three inherited abnormalities of fructose metabolism are known. Two of these are caused by a defect 
of one of the enzymes of the specialised fructose pathway: essential fructosuria and hereditary 
fructose intolerance - the former a harmless and the latter a potentially lethal condition. All three 
defects are inherited as autosomal recessive traits. Hereditary fructose intolerance is characterised 
by severe hypoglycaemia and vomiting shortly after the intake of fructose. Prolonged fructose 
ingestion in infants leads to poor feeding, vomiting, jaundice, haemorrhage, proximal renal tubular 
syndrome, and finally, hepatic failure and death. Patients develop a strong distaste for noxious food. 
Therefore, a chronic course is observed only in preschool-aged children. Fructose 1-phosphate 
aldolase of liver, kidney cortex and small intestine is deficient. Hypoglycaemia after fructose 
ingestion is caused by fructose 1-phosphate inhibiting glycogenolysis at the Phosphorylase level and 
gluconeogenesis at the mutant aldolase level. Patients remain healthy on a fructose- and sucrose-free 
diet. 
Galactosemia 
Three inherited disorders of galactose metabolism have been described. The genetic disturbance 
(autosomal recessive) is expressed as a cellular deficiency of either galactokinase, galactose 1-
phosphate uridyl-transferase or uridine diphosphate galactose 4-epimerase, which convert 
galactose to glucose. The clinical manifestations in infants are toxicity syndromes resulting from 
exposure to galactose. Toxicity symptoms include cataracts inanition, failure to thrive, vomiting, 
liver disease, cataracts, and developmental delay. Despite initiation of a lactose-free diet, which 
alleviates the acute toxicity, there are long-term complications in transferase-deficient patients. 
These consist of poor growth, speech abnormalities, mental deficiency, neurologic syndromes and 
ovarian failure in females. 
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Prevalence of adverse reactions to food 
Prevalence of food allergy and putative food allergy 
Although there is a better recognition of food allergy, its real prevalence has only been investigated 
in very few studies. Prospective, population-based studies are required to assess the true incidence of 
food-allergic diseases. The rate of food intolerance or of food allergy depends on the methods used. In 
response to a questionnaire, the number of people who think they have experienced adverse reactions 
to foods may be as high as 33%'
142'. However, when appropriate tests are used this percentage 
decreases sharply'
143·
144'. 
The prevalence of cow's milk allergy and intolerance has been examined in a number of retrospective 
and prospective studies and estimates of prevalence range from 0.1 to 7.5%"
45'. It seems, however, 
that a more realistic rate is ranging from 1 to 3%'
146"
149'. This variation mainly reflects differences in 
criteria for diagnosis, differences in study design, and possibly differences in diets accounting for 
geographical differences. Moreover, in many studies, allergy and non-immunologie intolerance was not 
differentiated'
150"
152'. 
A survey of 1,483 Dutch adults'
143' revealed that the prevalence of perceived food additive 
intolerance/allergy was 1.6% with 13.3% reporting intolerance/allergy to any foodstuff. Of the 198 
subjects with self-reported food intolerance/allergy 90 were subjected to clinical histories and to skin-
prick testing. Of these, 54 had possible allergy or intolerance to foods (i.e. 3.6% of the population). 
Based on further investigation involving elimination diets and open food challenge, adverse reactions 
to foods could only be confirmed in 25 (1.7% of the population). Double-blind, placebo-controlled food 
challenge reduced the number to 12 or 0.08% of the population. Only two of these subjects had an 
adverse reaction to food additives giving prevalence of 13 per 10,000 of the population. 
In a Danish study, 335 atopic children aged 4-15 years were questioned about hypersensitivity and 
22.7% implicated food additives. An open challenge with food additives reduced this figure to 6.9% 
and a double-blind challenge reduced this further to 1.8%. A second and similar study investigated 
173 children reporting hypersensitivity. In an open challenge with food additives 9.8% revealed a 
positive reaction while a double blind challenge of twelve of these positive children reduced the 
prevalence to 3.5%. The combined results revealed a prevalence of 2% with open challenge and the 
double blind challenges would indicate the true prevalence of intolerance to food additives to be 
1%"
53'. 
A survey of 18,582 subjects in the UK showed that 7.4% had a perceived adverse reaction to food 
including food additives with 1.4% reporting an adverse reaction only to food additives'
154'. Of those 
who reported an adverse reaction to food additives, 89.1% indicated their willingness to attend for a 
further interview. Of the 649 who attended for interview, 132 subjects were submitted to a clinical 
evaluation of adverse reactions to food additives of which 81 completed the trial. Of these 81, three 
showed consistent reactions to low or high doses of food additives. On that basis, the population 
prevalence to food additives was put at 0.026% or about 3 people per 10,000 of the population. 
Bousquet et al (unpublished data) studied the prevalence of positive skin tests to the seven most 
common foods of the Montpellier area in a representative sample of 2500 men and 2500 women (20 to 44 
years of age) selected according to the EC epidemiological study on Respiratory Health"
55'. The 
prevalence of positive skin tests to inhalant allergens was around 25% but only 1.3% of the subjects 
had a positive skin test to one food type. Moreover, symptoms of food allergy were observed in only 
50% of these subjects. 
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To determine the prevalence of food allergy as a cause of exacerbation of asthma, Onorato et al . 
studied 300 consecutive patients with asthma (7 months to 80 years of age) who attended a 
respiratory clinic'
156'. Each patient was screened for possible food allergy by means of a questionnaire 
and by skin prick tests with the six food allergens most common in the area. Patients with either a 
suggestive history and/or a positive prick test and/or RAST underwent a double-blind food challenge 
with lyophilised food in capsules or food mixed up into a broth to disguise its taste. Pulmonary 
function tests and symptoms were followed for 8 hours after each challenge. Of the 300 patients 
screened, only 25 had either a history or skin prick tests or RAST responses suggestive of food allergy. 
Twenty patients had interpretable food challenges. In these 20 patients, food challenge caused 
asthma in six and caused other symptoms (atopic dermatitis and gastrointestinal symptoms) in five. 
The prevalence of asthma due to food allergy was below 1% in adults. 
The prevalence of sulfite sensitivity in the general population is unknown and in asthma reports on a 
small number of patients have lead to a variable prevalence. Both adults and children can suffer from 
sulfite-induced asthma. It appears that patients with severe asthma, such as steroid-dependent 
bronchial asthma present a greater prevalence of sulfite sensitivity'
157'. Some reports suggest a 
prevalence of sulfite sensitivity in at least 5% of the asthmatic population'
158'. However, a very 
careful study proposed that on the basis of challenges, the best estimate of the prevalence of sulfite 
sensitivity in the asthmatic patients studied is 3.9%. This population, however, contained a larger 
number of steroid-dependent asthmatic patients than would be found in the general asthmatic 
population. It was concluded, therefore, that the prevalence of sulfite sensitivity in the asthmatic 
population as a whole would be less than 3.9% and that steroid-dependent asthmatic patients are 
most at risk'
159'. 
These studies combine to indicate that using double-blind food challenge, the prevalence of food 
allergy is far below 1% of the population in adults and may be slightly greater in children'
160'. 
However, this may be a low estimate since food challenge may not identify the entire population of 
food allergic individuals and there are some genetic and environmental factors that can increase the 
prevalence, of food allergy. 
The prevalence of food allergy is highly dependent on geographical area. In areas where sensitivity 
to birch and mugwort pollen is prevalent, 30 to 50% of these patients present symptoms when ingesting 
fruits and vegetables. Thus, in these areas, the prevalence of food allergy in adults may be as high as 
5 to 6%. The diet of a given country is also of importance, for example, peanut allergy was very 
common in the US but since this food has been widely marketed throughout Europe it is now a major 
allergen both in the US and Europe. Shrimp allergy is common in Southern USA, fish allergy is 
common in the Nordic countries and Japan because in these countries these foods are commonly 
ingested. It has been found that fish allergy may be as high as 3% in 3-year old Finnish children'
16". 
Prevalence of metabolic disorders and coeliac disease 
Lactose intolerance is widespread among certain ethnic groups. A deficiency of lactase is common in 
the Mediterranean, parts of Africa and in Asia'
162'. 
Estimates of the prevalence of transferase deficiency galactosaemia based on the detection of 
heterozygotes in Wales, Denmark and the United States range from 1; 18,000 to 1: 180,000. The 
prevalence at birth has been 1: 70,000 in the British Isles. In a large-scale screening programme in 
New York State involving 141,000 infants, a prevalence of 1: 35,000 has been detected, while the 
frequency in Massachusetts is 1: 190,000'
163'. The incidence in Belgium and Switzerland is 
approximately 1 in 62,000. Galactosaemia occurs with a frequency of 1 in 300 among the community of 
Irish travellers, and 1 in 20,000 in the general population in Ireland. 
20 Reports of the Scientific Committee for Food (Thirty-seventh series) 22 SEPTEMBER 1995 ADVERSE REACTIONS TO FOODS AND FOOD INGREDIENTS 
Cases of hereditary fructose intolerance have been reported from Europe, North America, India, 
Australia and other parts of the world. The true incidence is not known but may be as high as 1: 20,000 
in Switzerland. Evidence is overwhelming that considerable numbers of children and adult patients 
must live undiagnosed in the general population'
164'. 
Cumulative incidence rates of coeliac disease vary from 1 in 300 (in Sweden) to 1 in 3,500 in the South 
West of France (region of Toulouse), being around 1 / 1000 in England and Central Europe (Germany, 
Austria, Switzerland). Incidence rates vary also with time, decreasing in England, rising sharply in 
Sweden (from 1 / 100 to 1 / 300 during the last 10 years), stable elsewhere"
65'. 
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EXPRESSED ON 22 SEPTEMBER 1995 
Terms of reference 
To advise on the safety-in-use of mineral and synthetic hydrocarbon oils and waxes for use as food 
additives, in food processing and for use in food packaging materials. 
Background 
Types of mineral and synthetic hydrocarbons 
Food grade mineral hydrocarbons are produced as by-products during the refining and distillation of 
crude mineral oils. Oils can be manufactured by two routes, the modern hydrogénation method and by 
the older acid (oleum) treatment. There are three main types of products; liquids, semi-liquids and 
solids, examples of each being mineral (white) oils, petroleum jellies and mineral waxes. Petroleum 
jellies are prepared by mixing oils and waxes so only mineral oils and mineral waxes need be 
considered when assessing the safety of mineral hydrocarbons. 
There is a wide variation in the composition of these oils and waxes, resulting from the use of a range 
of crude oil starting materials, and most products are complex mixtures. This poses problems in 
developing meaningful specifications for these products, an issue which we address in more detail 
later. Mineral hydrocarbons may be straight chain (normal paraffins), branched chain (non-normal 
paraffins) or cyclic (naphthenics). For the paraffinics, the chain length may vary within the 
approximate range Cjs-Cgo- The oils are generally described according to the predominant type of 
material present, as either paraffinic or naphthenic, but paraffinic oils may contain some cyclic 
structures, and similarly naphthenic oils may contain some straight and branched chain paraffins. 
Mineral waxes contain mainly paraffinic hydrocarbons, with only very low levels of saturated cyclic 
naphthenic structures. It is the ratio of straight chain to branched chain paraffinic hydrocarbons, and 
to a certain extent molecular weight, which determine whether the wax is classified as a paraffin, 
intermediate or macrocrystalline wax. Paraffin waxes contain mainly straight chain components with 
the proportion of branched chain components varying from as low as 5%; the proportion of branched 
chain components increases as average molecular weight increases. Intermediate waxes have higher 
average molecular weights than paraffin waxes and consist of approximately equal proportions of 
straight chain and branched chain alkanes. Microcrystalline waxes have the highest average 
molecular weight and contain mainly branched chain components with less than 30% straight chain 
alkanes. 
Hydrocarbon waxes which are completely synthetic can also be produced by the Fischer-Tropsch 
process (passage of steam over hot coal). These too will be mixtures of components with varying chain 
length, but comprise mostly straight chain components only. 
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Uses 
Mineral hydrocarbons have been widely used in many different applications which can potentially 
give rise to residues in food. Past or present uses include direct food additives (e.g. as glazing agents), 
constituents of chewing gum base, processing aids (e.g. lubricants), in food packaging materials (e.g. 
wax-coated cartons), in cheese wax, in pesticide formulations, as adjuvants in veterinary medicines, 
and in human medicines (e.g. liquid paraffin laxative). Within Europe, their uses as direct food 
additives have diminished and in some countries they are not permitted for food additive use. 
Natural occurrence in food and environmental contamination of food 
In addition to deliberate uses in foods, food processing and food packaging, the diet will also contain 
other hydrocarbons due to biosynthesis of hydrocarbons in terrestrial and marine plants and animal 
species and from environmental contamination of foods such as fish and shellfish resulting from 
geological activity, drilling of crude oil, oil and petroleum spillages and combustion of petroleum and 
other fossil fuels. Saturated and unsaturated n-alkanes with chain lengths of C15, C17 and C21 are 
predominant in marine organisms, whilst saturated n-alkanes of chain lengths C27, C29 and C31 are 
typical of terrestrial plants. 
Previous Scientific Committee for Food (SCF) evaluation 
The SCF considered the use of food-grade mineral hydrocarbons in May 1989 (1). At that time, two 90-
day feeding studies in Fischer 344 (F344) rats, sponsored by industry, revealed that the two mineral 
oils tested, an oleum (acid) treated oil and an oil produced by the hydrogénation method, deposited in 
organs such as the spleen, liver and lymph node and were accompanied by histological abnormalities 
in these organs and consequential haematological abnormalities (2-4). During its review the 
Committee also noted that there were still many unresolved problems over the specifications for 
mineral hydrocarbon compounds. The SCF concluded that the available data did not permit an 
Acceptable Daily Intake (ADI) to be set, and that there was no toxicological justification for the 
continued use of mineral hydrocarbons as food additives. However, the Committee advised that there 
was no evidence of an acute health hazard to warrant urgent action to change the present pattern of 
the use of these compounds in food. 
The Committee did use the 90-day studies to set two temporary Tolerable Daily Intakes (TDI) to 
cover residues in food arising from the use of mineral hydrocarbons in packaging materials. The t-TDIs 
were 0.005 mg/kg bw for oleum treated mineral hydrocarbons and 0.05 mg/kg bw for hydrocarbons 
produced by the hydrogénation method. The SCF stated that continued use of these materials was 
conditional on new short-term studies on well-specified mineral oils being performed by the end of 
1990, followed by long-term studies completed within 5 years of the date of the SCF review (1). 
Current review 
Several new studies and reviews were sponsored by industry following requests for further data on 
these materials by the SCF and other regulatory bodies (5-15). The materials tested in these studies 
were chosen by the industry as being representative of mineral hydrocarbons currently used in food, in 
the sense that they had physical properties covering the range of the then used materials, from low 
viscosity oils through to waxes. A preliminary study on straight-chain, synthetic waxes has also been 
completed recently (12). We were also informed of another study carried out by industry on straight 
chain, synthetic waxes (known as Waxes A, Β and C). Limited information but no study report has 
been made available to the SCF on these three waxes (13). 
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Since the Committee had only very limited data available to it on the likely exposure to mineral 
hydrocarbons from any of its food uses, it has not been possible to make any reliable estimates of 
intakes. We understand that in addition to work already published (16-20), the industry is gathering 
further information on migration of mineral hydrocarbons from food packaging materials into foods 
and is generating consumption data for the US population. We welcome this but in the absence at 
present of adequate exposure information relating to the EU, the opinion which follows is therefore a 
hazard assessment, not a risk assessment. 
Evaluation of effects observed in animals and humans 
The majority of animal studies have been carried out on the F344 rat which appears to be more 
sensitive to mineral hydrocarbons than other strains of rat. However, there is no information on 
whether humans may be more or less sensitive to mineral hydrocarbons than the F344 rat and we 
therefore considered it prudent to base our assessment on the results available in the F344 strain of rat. 
From the available data on animals (2-12) and humans (21-32), it is clear that some mineral and 
synthetic oils and waxes not only accumulate with repeated dosing, but also give rise to effects which 
are not confined solely to localised foreign body reactions and provide clear evidence of toxicity in 
animals. In those oils and waxes which did show effects, the effects seen were similar in nature but 
differed in severity, i.e. some only gave rise to significant effects at a 2% level in the diet whereas 
others produced effects at 0.02%, with very occasional findings at 0.002%. The following effects were 
observed: increased organ weights, especially liver and lymph nodes; altered serum enzyme levels; 
increased monocyte and neutrophil counts; reduced red blood cells, haemoglobin, haematocrit, MCHC, 
MCH; and the accumulation of hydrocarbon material in tissues. The main histopathological findings 
were granulomata in the liver and focal collections of vacuolated macrophages (histiocytosis) in the 
lymph nodes. In animals dosed with certain of the waxes, an inflammatory lesion at the base of the 
mitral valve in the heart was observed. It was characterised by increased cellularity of the valve 
with destruction of the fibrous core. In some animals given these waxes, biréfringent hydrocarbon 
material was detected in the mitral valve region, but the inflammatory lesion was not always 
accompanied by a significant level of hydrocarbon material in the valve; similarly, the presence of 
biréfringent material was not always accompanied by an inflammatory lesion. None of the oils tested 
produced this lesion. In those studies which included a withdrawal phase, most of the toxic effects 
were still evident at the end of the withdrawal period but there was limited evidence that the 
severity of some of these effects had decreased during this phase. In all studies, female rats appeared 
to be more susceptible than male rats. 
Samples of liver tissue from a small number of rats were analysed and the accumulated mineral 
hydrocarbons were found to be comparable but not identical to the original oil/wax administered. 
Lower and higher molecular weight hydrocarbons were under-represented in the liver extracts 
compared with the original test sample and the branched chain content of the residues was relatively 
higher than in the original test sample. 
The data indicate that toxicity is correlated with accumulation. In animal studies, of those mineral 
and synthetic hydrocarbons which did accumulate, the degree of accumulation was generally highest 
in those showing most toxicity and lowest in those materials producing little or no accompanying 
toxicity. In all groups tissue levels declined following withdrawal of dosing. Two of the human 
population studies also showed a clear correlation between the extent of the lesions and the amounts 
of mineral hydrocarbons which could be extracted from the tissues (25,27). 
Reports of the Scientific Committee for Food (Thirty-seventh series) 33 22 SEPTEMBER 1995 MINERAL AND SYNTHETIC HYDROCARBONS 
It is not possible to predict the ultimate consequences for health of the reactions observed in some of 
the animal studies, such as the inflammatory reactions in the liver and the mitral valve of the heart. 
However, we consider that these and some of the other effects noted above are undesirable and 
further consider that there are sufficient parallels between the observations of accumulation and 
effects in animals and man to conclude that there is the potential, depending on the intake, for 
adverse effects on human health. For those hydrocarbons which have been shown to both accumulate 
and cause toxicity, for which a no adverse effect level is not yet known, (i.e. oils: N10(A), N15(H), 
P15(H), N70(H), N70(A); and waxes: LMPW, IMPW, M5, M5DO, C80, A, Β and C), it is not possible 
from current information to set a safe level for intake from food. Further research might identify such 
levels. 
One of the tested mineral hydrocarbon oils, the P100(H), showed minimal accumulation but no 
toxicity within the duration of a 90-day study. Whilst longer term studies would be necessary to 
ensure that such oils did not eventually give rise to toxicity, it seems likely, as a generalisation, that 
there may be low levels of accumulation of mineral and synthetic hydrocarbons which are of no 
toxicological significance. Indeed, it is clear from the animal tissue reversal studies that the body is 
able to metabolise and clear much of what is absorbed in the absence of any further intake. 
Unfortunately, there is no information on whether there might be an equilibrium point at which 
regular but low intakes of certain mineral and synthetic hydrocarbons with a lesser tendency to 
accumulate might be cleared successfully by the body without any long-term sequelae. Kinetic and 
dose/response information from tissue reversal studies would have helped elucidate this point but, to 
date, only 2% dietary dose groups have been studied at a single time point. In the absence of further 
information on this point at present, but bearing in mind the capacity of the body to clear smaller 
amounts of material and the lack of toxicity seen with the P100(H) oil, we consider P100(H) oil as 
temporarily acceptable, subject to a satisfactory specification and the submission of further data (see 
below). We understand that further in vitro and in vivo studies on the kinetics of mineral hydrocarbon 
absorption, metabolism and clearance are underway and we welcome this. 
The P70(H) oil also deserves separate consideration. It showed accumulation in liver, lymph node and 
kidney which was slightly greater than that seen with the P100(H) oil but was not as extensive as 
that seen with the other oils which showed toxicity in 90-day studies. Whilst some organ weight, 
clinical chemistry and haematological changes were noted with the P70(H) oil, these changes were 
small in magnitude, with little or no evidence of relationship to dose, and no significant histological 
lesions such as granulomata in the liver or histiocytosis in the lymph nodes were seen. We therefore 
consider P70(H) as temporarily acceptable, to be included in a temporary Group ADI together with 
P100(H) oil (see below). 
Two of the mineral hydrocarbons tested, the microcrystalline high sulphur wax (HSW) and high 
melting point wax (HMPW), neither accumulated nor showed any toxicity in the 90-day and reversal 
studies carried out. Similarly, the synthetic H2 wax showed no toxicity and, whilst it has not been 
tested in a tissue accumulation and reversal study, the physical parameters of its specification are 
comparable with those of the HSW and HMPW. We therefore regard the microcrystalline HSW and 
HMPW, and the synthetic H2 wax as acceptable for food use, provided a specification can be set for 
these materials which would exclude the likelihood of significant quantities of cumulative/toxic 
components being present (see below). 
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Specifications 
Central to deciding whether to recommend some mineral hydrocarbons as acceptable for food use was 
the question of specifications. As mineral hydrocarbons are complex mixtures derived from varying 
sources, they can only be described loosely in chemical terms, rather than fully characterised 
chemically in the detailed manner of most other food additives. It is therefore necessary also to 
describe them by means of their physical characteristics. The loose chemical descriptions and 
physical characteristics describe products as sold. Thus we are aware that products with similar 
physical descriptions may differ in the detail of their chemical constituents; indeed, a single named 
product sold by one producer may vary over time. It follows that the mineral hydrocarbons used in the 
toxicity tests cannot be reproduced exactly for marketing. We have therefore considered very 
carefully the question of whether the toxicity observed with some materials could be caused by very 
small proportions of unusual, highly toxic components, whose presence in products defined mainly by 
physical characteristics could be unpredictable and uncontrollable. We consider that the totality of 
the evidence now available on both mineral and synthetic hydrocarbons is sufficient to enable us to 
reach a view that such a possibility is very unlikely. Rather we have concluded that it is largely the 
amounts of lower molecular weight, shorter chain-length substances, which are absorbed and only 
slowly cleared from the body, that most probably determine the occurrence or absence of toxicity. 
Accordingly, we consider that, for practical purposes for the time being, mineral and synthetic 
hydrocarbons could be defined by physical specifications which are sufficiently tightly drawn so as 
to ensure that only a small proportion of any product conforming to these specifications will have 
carbon chain-lengths in the absorbable range. 
The envelope specifications proposed (see below) exclude all the mineral and synthetic hydrocarbons 
tested to date which showed some toxicity in 90-day studies, but include the P70(H) oil, P100(H) oil, 
HSW, HMPW and H2 wax which did not. However, we urge that further efforts are made to improve 
and refine the specifications within this envelope specification for any mineral or synthetic 
hydrocarbons which are marketed for food use. 
Acceptable Daily Intakes and further research 
We have considered the setting of Acceptable Daily Intakes (ADI). In addition to their diversity, 
complexity and the difficulties of chemical characterisation, mineral and synthetic hydrocarbons 
also differ from other more conventional food additives in the general lack of studies conducted to 
modern day standards on aspects of toxicity other than general toxicity and mutagenicity. We have 
again given this matter careful thought, noting that recent long-term rat and mouse carcinogenicity 
studies with a complex mixture of chlorinated paraffins, which produced similar effects such as 
lymph node histiocytosis, liver granulomata, congestion in the spleen and accompanying clinical 
chemistry and haematological changes, did not adversely affect survival or tumour rates (33). 
We consider that since the envelope specification we propose for waxes largely excludes absorbable 
materials, the possibility of toxic effects other than those which would show up in a 90-day study is 
remote for waxes falling within that specification. Accordingly we have used the usual safety factor 
of 100 applied to the no-effect level for the waxes (i.e. 2% in the diet in 90-day studies) to set a Group 
ADI of 0-20 mg/kg bw for the highly refined microcrystalline and synthetic waxes which conform to 
the envelope specification. We require no further data on these waxes. 
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For white paraffinic mineral oils which conform to the envelope specification for oils, we have used a 
safety factor of 500 applied to the 90-day no-effect level of 2% in the diet for the P100(H) oil and the 
90-day minimal effect level of 2% in the diet for increased liver weight for the P70(H) oil, in order to 
set a temporary Group ADI of 0-4 mg/kg bw. This ADI is temporary pending submission within 4 years 
of a 2-year chronic toxicity/ carcinogenicity study on P70(H) oil, to include a satellite group dosed for 
1 year only and then left untreated for a further year. This would provide information on whether or 
not the very limited accumulation observed with these oils in the 90-day studies would give rise to 
any toxicity if administration was continued for a longer period and information on the reversibility 
of any effects observed. Pending these results, a higher safety factor has been chosen because of the 
indication that there is some absorption and minimal accumulation of the P100(H) and P70(H) oils 
compared with no detectable accumulation of higher viscosity waxes of similar or longer average 
carbon chain-length distributions. The additional factor chosen over and above the usual safety factor 
of 100 is 5, rather than 2 as is usual for temporary ADIs, because of the nature of these uncertainties 
about absorption when viewed alongside the gaps in the toxicological database. 
Conclusions 
(i) There are sufficient data to allocate a full Group ADI of 0-20 mg/kg bw for waxes conforming 
to the following specification: 
Highly refined waxes derived from petroleum based or synthetic hydrocarbon feed stocks, 
with 
Viscosity not less than 11 mm^"
1 (centiStokes) at 100°C 
Carbon number not less than 25 at the 5% boiling point 
Average molecular weight not less than 500 
We do not require any further data on these waxes. 
(ii) There are sufficient data to allocate a temporary Group ADI of 0-4 mg/kg bw for oils 
conforming to the following specification: 
White paraffinic mineral oils derived from petroleum based hydrocarbon feed stocks, with 
Viscosity not less than 8.5 mm¥ (centiStokes) at 100°C 
Carbon number not less than 25 at the 5% boiling point 
Average molecular weight not less than 480 
We require a chronic toxicity/carcinogenicity study of 2 years duration on P70(H) oil, which includes 
a reversibility phase in which a satellite group dosed for 1 year is left untreated for a further year, to 
be submitted within 4 years. 
(iii) We urge that further efforts are made to improve and refine the specifications within the 
above envelope specifications, particularly with respect to better chemical characterisation, 
for any mineral or synthetic hydrocarbons which are marketed for food use. 
(iv) We would wish to see other relevant toxicological and exposure data which we understand 
are being generated on mineral hydrocarbons. 
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